| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_22a1b0a472de5e09d55763063f97b7ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8073450a491d200d05b09b9beb6f0ec6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19f04e912c42bb04a2f066f36ed6c99a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13d9ab184a6a3c429a9cc0986003041c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562e4af016953c0a80e09960559ed0d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fc6d4b28553d242ec1dfc6e136b00ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ef117cbf4556745aad693fc3d7347f8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2011-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93422e709f202200887075fa54464c5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_435f907de93996ce4e2cd09bd46478ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93d58d64acfc9f3108769505d39da8b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb8fe27df59ba721b987abc55265811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4e6dde3930c2518eb0e003670ba4d7c |
| publicationDate |
2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013260376-A1 |
| titleOfInvention |
Prediction of and Monitoring Cancer Therapy Response Based on Gene Expression Profiling |
| abstract |
The invention utilizes gene expression profiles in methods of predicting the likelihood that a patient's cancer will respond to standard-of-care therapy. Also provided are methods of identifying therapeutic agents that target cancer stem cells or epithelial cancers that have undergone an epithelial to mesenchymal transition using such gene expression profiles. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3190416-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018191553-A1 |
| priorityDate |
2010-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |